Skip to main content
. 2024 Feb 23;11(3):1612–1624. doi: 10.1002/ehf2.14710

Figure 1.

Figure 1

Study flow chart detailing the inclusion and exclusion criteria for the study patients. AL cardiac amyloidosis, immunoglobulin light‐chain cardiac amyloidosis; TTE, transthoracic echocardiography.